Skip to main content
Clinical Trials/NCT07227662
NCT07227662RecruitingNot Applicable

Feasibility, Usability and Preliminary Efficacy of Home-based FES Fro Adhesive Capsulitis

University of Maryland, Baltimore2 sites in 1 country10 target enrollmentStarted: June 1, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
10
Locations
2
Primary Endpoint
Participant Acceptability and Satisfaction

Study Overview

Brief Summary

The purpose of this study is to investigate the feasibility, usability and preliminary efficacy of a home-based Functional Electrical Stimulation(FES) in individuals with shoulder adhesive capsulitis. The main question it aims to answer is if combining home-based FES to usual therapy at the clinic will improve pain and improve function of the impaired shoulder.

Detailed Description

Individuals with shoulder adhesive capsulitis will be recruited. All participants will complete clinical assessments at 3 time points(baseline, 2 weeks into the intervention and 4 weeks after). Each participant will be asked to complete either one 60min or 2x30 min duration of FES daily for 4 weeks.

The following assessments will be performed:Likert rating scales and open-ended questions,The Disabilities the Arm, Shoulder, and Hand (DASH) questionnaire,Active and passive shoulder range of motion (ROM) will be assessed using goniometric measurements for shoulder flexion, abduction, and external rotation,Pain rating at rest, night, and end range movement using a visual analogue scale (0-10 points)

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Device Feasibility
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age > 18 years
  • •Individuals diagnosed with shoulder adhesive capsulitis
  • •Shoulder pain, limited shoulder mobility for more than 4 weeks, normal shoulder x-ray findings, and normal neurological exam
  • •Can tolerate electrical stimulation

Exclusion Criteria

  • •Presence of shoulder tumors or bone lesions
  • •History of shoulder fracture or subluxation
  • •History of shoulder surgery
  • •Severe osteoporosis,
  • •Rheumatic disease
  • •Radiating pain from cervical radiculopathy
  • •Participation in other clinical trial, and/or intraarticular steroid injections within 6 weeks

Arms & Interventions

Home-based FES

Other

The intervention will include home use of Genesis Flex FES device alongside usual rehabilitation care. Participant education in Genesis FES use will be conducted during the baseline assessment session. FES parameters will be initially adjusted at the lowest possible current for patient comfort with the constraint that they should not elicit a tetanic contraction. FES will be provided via two self adhesive electrodes attached across shoulder joint.A shoulder harness adjustable neoprene padding will be provided to enable anatomical contouring for patient comfort and support for positioning of stimulator and electrodes to the affected shoulder.

Intervention: Home based FES in combination with usual therapy (Device)

Outcomes

Primary Outcomes

Participant Acceptability and Satisfaction

Time Frame: At the end of 4 weeks

Participant-reported satisfaction, comfort, and ease of use assessed using a 5-point Likert scale and open-ended qualitative feedback.A Likert scale is a rating scale used in surveys to measure opinions, attitudes,and perceptions by asking respondents to indicate their level of agreement or disagreement with a statement. It consists of a series of statements with a symmetric range of response options, such as a five-point scale from 0="Strongly Disagree" to 5="Strongly Agree". This method allows for the collection of quantitative data to analyze subjective experiences.

Usability of the FES device for home-based use

Time Frame: At the end of 4 weeks

Percentage of participants able to correctly and independently use the portable FES device for ≥80% of prescribed home sessions, as verified by device logs and participant self-report.

Secondary Outcomes

  • Change in Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire score(Change from baseline DASH at 4 weeks)
  • Change in Active and Passive Shoulder Range of Motion (ROM)(Change from baseline ROM at 4 weeks)
  • Change in Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire score(Change from baseline DASH at 4 weeks)
  • Change in Active and Passive Shoulder Range of Motion (ROM)(Change from baseline ROM at 4 weeks)
  • Change in Shoulder Pain using Visual Analog Scale(Change from Baseline VAS at 4 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kelly Westlake

Professor

University of Maryland, Baltimore

Study Sites (2)

Loading locations...

Similar Trials